Breaking News, Business, Financial and Economic News, World News from EconoTimes

Become a contributor

Bookmark Econotimes

Mon, Dec 15, 2025 10:16 AM All times are UTC

Follow Series

©Econometrics LLC . All Rights Reserved.

S. Jay Olshansky

Professor of Epidemiology and Biostatistics, University of Illinois at Chicago
S. Jay Olshansky received his PhD in Sociology at the University of Chicago in 1984. He is currently a Professor in the School of Public Health at the University of Illinois at Chicago, Research Associate at the Center on Aging at the University of Chicago and at the London School of Hygiene and Tropical Medicine, and Chief Scientist at Lapetus Solutions, Inc. The focus of his research to date has been on estimates of the upper limits to human longevity, exploring the health and public policy implications associated with individual and population aging, forecasts of the size, survival, and age structure of the population, pursuit of the scientific means to slow aging in people (The Longevity Dividend), and global implications of the re-emergence of infectious and parasitic diseases. Dr. Olshansky is on the Board of Directors of the American Federation of Aging Research; he is the first author of The Quest for Immortality: Science at the Frontiers of Aging (Norton, 2001) and A Measured Breath of Life (2013); and co-edited Aging: The Longevity Dividend (Cold Spring Harbor Laboratory Press, 2015). In 2016, Dr. Olshansky was honored with the Donald P. Kent Award from the Gerontological Society of America, the Irving S. Wright Award from the American Federation for Aging Research, and he was named a Next Avenue Influencer in Aging.

Millions are rejecting one of humanity's best weapons for saving lives: Vaccines

Jun 20, 2021 12:20 pm UTC| Insights & Views

A federal judge has dismissed a lawsuit filed by employees at a Houston hospital who did not want to be vaccinated for COVID-19, claiming that COVID-19 vaccines are unsafe. In the June 12, 2021 ruling, U.S. district Judge...

Economy

Asian Technology and Chipmaking Stocks Slide as AI Spending Concerns Shake Markets

Asian technology and chipmaking stocks fell sharply on Monday as investor caution intensified over growing uncertainties surrounding artificial intelligence (AI) spending and its impact on future earnings. The sell-off...

China’s November Economic Data Signals Slowing Industrial Output and Weak Consumer Demand

Chinas economic momentum showed further signs of strain in November as key indicators pointed to slower growth in industrial output and a sharper-than-expected slowdown in consumer spending, according to official data...

Oil Prices Rebound as U.S.-Venezuela Tensions Offset Oversupply Concerns

Oil prices edged higher on Monday, recovering part of last weeks sharp decline, as rising geopolitical tensions between the United States and Venezuela fueled concerns over potential supply disruptions. These worries...

Dollar Struggles as Markets Eye Key Central Bank Decisions and Global Rate Outlooks

The U.S. dollar remained under pressure on Monday, extending losses near a two-month low, while the euro and British pound held relatively steady as investors awaited a series of critical central bank decisions this week....

Asian Stocks Slide as Central Bank Decisions and Key Data Keep Investors Cautious

Asian stock markets opened the week lower as investors reduced risk exposure amid thin year-end liquidity, looming central bank decisions, and a packed schedule of delayed economic data releases. Early Monday trading saw...

Politics

Special Prosecutor Alleges Yoon Suk Yeol Sought North Korea Provocation to Justify Martial Law

A South Korean special prosecutor has accused former President Yoon Suk Yeol of attempting to provoke North Korea into an armed confrontation as part of an alleged plot to justify the declaration of martial law in December...

Supporters Gather Ahead of Verdict in Jimmy Lai’s Landmark Hong Kong National Security Trial

Supporters of Hong Kong democracy activist and media tycoon Jimmy Lai queued overnight outside the citys High Court on Monday as anticipation grew ahead of the verdict in his landmark national security trial, a case that...

Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership

Korea Zincs board is set to convene on Monday to vote on a major overseas investment plan that could significantly strengthen the supply chain for critical minerals in the United States. According to a source familiar with...

Hong Kong Democratic Party Disbands After Member Vote Amid Security Crackdown

Hong Kongs last major opposition party, the Democratic Party, has voted to disband, marking a significant moment in the citys political history and underscoring the impact of Chinas national security crackdown on liberal...

Ukraine’s NATO Concession Unlikely to Shift Peace Talks, Experts Say

Ukraines recent offer to abandon its long-standing ambition to join NATO is unlikely to have a major impact on ongoing peace talks with Russia, according to several foreign policy and security experts. During discussions...

Science

Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman

The U.S. Senate Commerce Committee announced it will vote on December 8 on President Donald Trumps renewed nomination of private astronaut and tech entrepreneur Jared Isaacman to lead NASA. Isaacman, known for his...

NASA Cuts Boeing Starliner Missions as SpaceX Pulls Ahead

NASA has significantly scaled back Boeings Starliner program after years of technical issues and delays, announcing that the next Starliner mission to the International Space Station (ISS) will fly without astronauts. The...

Blue Origin’s New Glenn Achieves Breakthrough Success With First NASA Mission

Blue Origins massive New Glenn rocket marked a major milestone as it completed its first mission for paying customers, sending two NASA satellites toward Mars and successfully landing its reusable booster at sea. The...

Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment

Cogent Biosciences (NASDAQ: COGT) shares skyrocketed over 120% after the biotech company announced groundbreaking results from its Phase 3 PEAK trial evaluating bezuclastinib in combination with sunitinib for patients with...

Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage

U.S. President Donald Trump and German pharmaceutical company Merck KGaA have announced a groundbreaking deal aimed at lowering the cost of in-vitro fertilization (IVF) treatments while boosting access to fertility care in...

Technology

iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures

iRobot, the company behind the popular Roomba robotic vacuum cleaner, has filed for Chapter 11 bankruptcy protection in the United States as it prepares to go private through an acquisition by Picea Robotics, its primary...

Nvidia Weighs Expanding H200 AI Chip Production as China Demand Surges

Nvidia is evaluating whether to expand production capacity for its powerful H200 artificial intelligence chips after demand from Chinese customers significantly exceeded current supply, according to multiple sources...

SpaceX Begins IPO Preparations as Wall Street Banks Line Up for Advisory Roles

SpaceX has reportedly begun the early stages of preparing for a potential initial public offering (IPO), marking a significant milestone for the private aerospace company founded by Elon Musk. According to a report from...

SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation

SpaceX, the aerospace company founded by Elon Musk, has reportedly authorized an insider share sale that places its valuation at approximately $800 billion, according to a Bloomberg News report published Friday. The move...

Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand

Mizuho Securities has raised its price target on Broadcom Inc. (NASDAQ: AVGO), highlighting accelerating momentum in the companys artificial intelligence business and a rapidly expanding long-term backlog. The brokerage...